Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

Condition:   Melanoma Interventions:   Drug: tunlametinib;   Drug: paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin Sponsor:   Shanghai Kechow Pharma, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials